Skip to end of metadata
Go to start of metadata

Decisions:

 Summary

Description

  





Action Items:

Summary
Description
Responsible
Due Date







 

 








 

Notes/ Discussion items:

Details:

Details of Transition Plan will be provided by email

Doc we will be working in can be found at https://docs.google.com/document/d/1gzA29bICFoiOs8hXjd4O7ZQGh1UzmuF_KfRSOHiXNdo/edit#

Present-1/12/2021

Each L2 Director & Deputy review your section of the doc and make any updates/changes, conferring with your L3 managers as needed.  

1/13-14/2021

Review of full doc by all L2s. Please indicate when you have completed your review here:

CEE/Kelly:

ECSS/Bob & Phil:

XCI/Dave:

Ops/Greg:

RAS/Dave:

Pgo/Ron:

1/15/2021

John/Tim review plans from each area and provide feedback.  

1/18/2021

Each L2 area makes changes based on John/Tim’s feedback

1/19/2021

John/Tim do final review to resolve any issues

1/20/2021

ER copyedit of document

1/21/2021

Leslie to format final doc in Word

1/22/2021

John’s final review and deliver to NSF.


Spell out first instances of any acronyms in every major section of the report.

IPR14 will be followed closely by PY11 planning in mid-February

Scheduled will be emailed in mid January.

Risk review - n0 new risks, none retired

PCRs - there are 5 submitted and approved - using JIRA is a smooth

Recommendations - addressed 90% within 90 days, this is great!

Have 4 open recommendations - all assigned to Program Office

Staff Publications - 16 reported in RP2, please remind your area to enter this.

Wiki reminders: internal project tools are maintained on the wiki; also a link to User News page.

Appreciation to Leslie from the Evaluation Team 

 


 


  • No labels